Home › Interstitial Lung Diseases › Pennsylvania
Interstitial Lung Diseases clinical trials in Pennsylvania
19 studies for Interstitial Lung Diseases are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Thomas Jefferson University, Philadelphia
- Temple Lung Center, Temple University, Philadelphia
- UPMC Montefiore, Pittsburgh
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 29, 2026 · NCT05798923Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA013, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07179380FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Pennsylvania, Philadelphia
- Temple University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07540988A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
- Temple Lung Center, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06806592A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Pittsburgh
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Pennsylvania, Philadelphia
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 8, 2026 · NCT07201922A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06572384Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Thomas Jefferson University, Philadelphia
- Temple University of The Commonwealth System of Higher Education, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632Dorothy P. and Richard P. Simmons Center for ILD Research Registry
- Michelle F MacPherson, Pittsburgh
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- St. Luke's University Health Network, Bethlehem
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
- and 2 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 2
Ages 8 to 60 · All sexes · Updated Aug 14, 2026 · NCT03630211Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Temple University, Philadelphia
- Thomas Jefferson University, Philadelphia
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Temple University, Philadelphia
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Pennsylvania State Hershey Medical Center and College of Medicine, Hershey
- Hospital of the University of Pennsylvania, Philadelphia
- Jefferson Honickman Center, Philadelphia
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Children's Hospital of Philadelphia, Philadelphia
RecruitingObservational study
Up to age 24 · All sexes · Updated Jun 22, 2026 · NCT04098445Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Apr 21, 2026 · NCT05746039Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Temple University Hospital-Temple Lung Center, Philadelphia
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.